Agency.com, Alliance Healthcare Information, BBDO, Hall & Partners Healthcare, and Targetbase are sponsoring an upcoming conference, Can Pharmaceutical and Medical Device Marketers Learn From the Automobile Industry? Yes...here's why.
Upcoming Conference, to be held April 8th, 2005, Provides Compelling New Thoughts on Pharmaceutical and Medical Device Marketing
Agency.com, Alliance Healthcare Information, BBDO, Hall & Partners Healthcare, and Targetbase are sponsoring an upcoming conference, Can Pharmaceutical and Medical Device Marketers Learn From the Automobile Industry? Yes...here's why. The conference will be held on Friday, April 8, 2005, at the Hyatt Regency Princeton, Princeton, New Jersey.
The conference will introduce many new and incisive thoughts regarding how Pharmaceutical and Medical Device companies can learn from other industries' best practices as they relate to DTC, more targeted communications, and compliance. Topics covered will include:
Upcoming/Add one
An expert lineup of speakers will feature Lewis G. Pringle, PhD, former EVP and Research Director of BBDO Worldwide and holder of the Chair of Marketing at Miami of Ohio University, currently Chairman of the Department of Managerial Economics and Professor of Marketing at Yorktown University; Thomas Abrams, R.Ph., MBA, Director, Branch Chief Marketing & Surveillance Branch 1 with DDMAC of the FDA; as well as other industry experts in the pharmaceutical and automobile markets.
The conference is free, by INVITATION ONLY, and will include breakfast and lunch. If you are interested in this conference and would like to be added to the invitation mailing list, please e-mail Sarah Schaeffer, sschaeffer@alliancehealthinfo.com.
Symbravo Outperforms Oral CGRP Inhibitors in Phase III Trial, With Faster, Sustained Migraine Relief
February 24th 2025Data from the Phase III EMERGE trial show treatment with Symbravo provided more rapid and sustained migraine relief with improved quality of life in patients who previously had an inadequate response to CGRP treatments.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
The Importance of Real-World Evidence in Medical Research and Drug Development
February 18th 2025The ongoing evolution of real-world evidence from a novel concept to a cornerstone of modern medical research signifies its growing importance and vast potential to improve personalized medicine, overall healthcare outcomes, and eventually democratization of scientific facts by general accessibility.